top online casino 。

The best-performing share of the whole index last year was aeronautical engineer ( ). Fast-forward to 2025 and has that huge growth in the value of Rolls-Royce shares gone into reverse? As if. In fact, the Rolls-Royce share price has soared So far this year, it is . Compared to 5% for the FTSE 100 as a whole, that is outstanding performance – again. What’s driving the share price gain To unpick the reasons behind this soaring price, I think it is useful to consider a few different factors. One is customer demand. After a very difficult time due to government-imposed travel restrictions and weak consumer demand during the pandemic years, airlines have been struggling to meet soaring demand, meaning they have been servicing planes and ordering new ones. Making aircraft engines is a difficult and costly business, so there are high barriers to entry. That gives the few dominant players, such as Rolls-Royce, pricing power. Another factor has been performance beyond the core civil aviation division. European governments have increased military budgets, helping Rolls’ defence division. Meanwhile its nuclear power generation expertise is coming increasingly into demand. But there have been internal factors at play too. Since the start of last year, new management has set very aggressive growth targets. So far, business performance has been strong. I think that, if Rolls-Royce continues to look on track to meet or even beat those targets, its share price could move up further even from here. The current of 21 may look high today (for my tastes, at least). However, if earnings grow strongly — as the company’s strategy suggests they could — the prospective P/E ratio looks to me as if it may actually still be potentially cheap from a . Potential for further gains – but no guarantees The thing that puts me off investing in Rolls-Royce – and I have no plans at the moment to buy the shares – is what else might happen. For example, what if the ambitious growth plan fails? Rolls has a history stretching back decades of mixed performance. Look at its roller-coaster earnings per share, for example. Its business involves large fixed costs and projects with timelines that can shift dramatically due to external factors like airframe manufacturers pushing back launch dates. I think the current price of Rolls-Royce shares reflects investor hopes that the company will deliver on its plans. So if that does not happen, I expect the share price could fall. Another significant but external factor that, again, Rolls has struggled with for decades is civil aviation demand shocks outside its control. The pandemic was just the latest in a long line of such shocks, from the 2001 US terrorist attacks to volcanic dust clouds grounding European aviation. I see a risk of some such event throttling demand again at some unknown future point. The current Rolls-Royce share price does not offer me enough margin of safety to compensate for such risks, as far as I am concerned.Infrastructure bonds may pull funds from stocks

HARRISBURG, Pa. (AP) — Former Philadelphia Eagles running back Wendell Smallwood Jr. has pleaded guilty to federal fraud charges after he was accused of submitting fraudulent tax returns and applications for hundreds of thousands of dollars in COVID-19 pandemic aid programs. The signed plea agreement was approved Friday by a federal judge in Delaware. Smallwood, of Mullica Hill, New Jersey, faces sentencing in May on the three fraud charges. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get updates and player profiles ahead of Friday's high school games, plus a recap Saturday with stories, photos, video Frequency: Seasonal Twice a weekRobbins LLP reminds investors of the class action filed on behalf of all persons and entities that purchased or otherwise acquired Humacyte, Inc. (NASDAQ: HUMA) securities between May 10, 2024 and October 17, 2024. Humacyte and its consolidated subsidiaries develop and manufacture off-the-shelf, implantable, and bioengineered human tissues. For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Humacyte, Inc (HUMA) Misled Investors Regarding its Manufacturing Practices According to the complaint, Humacyte is currently engaged in engineering and manufacturing Acellular Tissue Engineered Vessel (“ATEV”), also known as“Human Acellular Vessel,” which is a lab-grown blood vessel implant that can act as a replacement for an injured or damaged blood vessel. On August 9, 2024, Humacyte issued a press release announcing that the FDA“will require additional time to complete its review of its Biologic License Application (BLA) for the acellular tissue engineered vessel (ATEV) in the vascular trauma indication.” The press release disclosed in part, that,“[d]uring the course of the BLA review, the FDA has conducted inspections of our manufacturing facilities and clinical sites and has actively engaged with us in multiple discussions regarding our BLA filing[.]” On this news, the Company's stock price declined $1.29, or 16.4%, to close at $6.62 per share on August 12, 2024. The complaint further alleges that on October 17, 2024, the FDA released a Form 483 concerning Humacyte's Durham, North Carolina facility, which revealed violations, including“no microbial quality assurance,”“no microbial testing,” and inadequate“quality oversight.” On this news, the Company's stock price declined $0.95, or 16.35%, to close at $4.86 per share on October 17, 2024. Plaintiff alleges that during the class period, defendants failed to disclose to investors: (1) that the Company's Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) that the FDA's review of the BLA would be delayed while Humacyte remediated these deficiencies; and (3) that, as a result, there was a substantial risk to FDA approval of ATEV for vascular trauma. What Now : You may be eligible to participate in the class action against Humacyte, Inc. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by January 17, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP : Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Humacyte, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. A photo accompanying this announcement is available at MENAFN24122024004107003653ID1109028402 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.The electric vehicle market lost some juice earlier in 2024, but October showed a sector comeback with some serious battery power. According to Cox Automotive, new EV sales were up 2.3% for the month and have cleared one million units for the year to date. Cox attributed the growth to aggressive dealer incentives and attractive vehicle leasing deals. But that growth has yet to translate into success for sector portfolio players. A case in point is the benchmark Global X Autonomous & Electric Vehicles ETF (DRIV), which is losing ground, down -6.61% for the year. That's the trouble with EV stocks and funds, market mavens say. While the long-term glide path looks clear enough for electric vehicles, mile marker to mile marker, the sector isn't gaining much steam. Here’s why those troubles may continue in 2025 – with one huge potential exception. “There is a lot of opportunity in the EV market, but it still faces significant challenges, mainly geared around consumer confusion," says David Boice, CEO of Team Velocity, an automotive technologies firm in Washington, D.C. "The upsides are that EVs are changing how the government can incentivize vehicles, allowing OEMs to explore new tech, and cities are constantly expanding infrastructure for mass adoption and sustainability." The downsides, unfortunately, are stacking up right now. "A lack of resources leaves consumers uncertain; tax credits, charging time, and long-term savings are all things Americans need to understand before buying an EV," Boice says. "OEMs and dealers need to be providing clear messaging about their vehicles to make sure there is as little friction surrounding the EV purchasing process as possible.” Another issue vexing potential investors is how the Trump administration's EV policies will play out. "The biggest downsides right now have to do with affordability," says KC Boyce, vice president at Escalent, a global market research and data advisory firm. "If the EV purchase tax credit goes away under Trump 2.0 and automakers don't continue a relentless pursuit of affordable models, EV adoption will run out of juice." [Two-Week Free Access to Pro-Level Trading Tools] What the Experts Are Saying About EV Stocks With that framework in mind, where are EV stocks headed in what promises to be a tumultuous 2025? Here's a snapshot of what sector plays stand out and why. Tesla (TSLA). Elon Musk's favorite car company has seen its share price rise by 34% so far in 2024, comfortably ahead of the S&P 500 Index, which is up 26% for the year. When it comes to investing, companies that show they're in it for the long haul are almost always a good bet, and Tesla follows that script to the letter. "Tesla is an obvious choice as an EV favorite — they've practically defined the electric vehicles category," says Mark Whitley, founder and CEO at Whits Corporation, a sustainable technology firm in St. Louis, Mo. Investors shouldn't pay too much attention to the highly vocal Musk, but the Trump administration's aggressive stance on tariffs and EV credits is another story. "Despite Elon Musk saying he wants Trump to kill EV tax credits, Tesla benefits greatly from the current regulatory regime," Boyce says. Chargeback (CHPT). This Campbell, Cal.-based electric vehicle charging network provider went public last March via a special purchase acquisition company (SPAC) deal and has plummeted over 90% since the rollout. Yet the company operates 315,000 charging ports in the US and abroad, giving it a big advantage in a burgeoning industry. It also has over one million roaming charging points, which represents a robust number in another growing EV sector. The company's broad-based operational stance should eventually stabilize the stock price, but it also has other advantages. "Let's not forget the infrastructure part," Whitley says. "Companies like ChargePoint, which focuses on electric vehicle charging solutions, are a way to invest in the sector without betting on any specific vehicle." BHP Group, LTD (BHP). This nickel mining company is a good supply/demand stock right now, as nickel is one EV-linked commodity company that can take advantage of rising EV battery needs. The stock is down 24% for the year, but with production pressures pushing nickel demand up, BHP may make sense for sector investors over the long haul. "There's potential in businesses that develop EV infrastructure, like battery technology and charging networks," says Dre Villeroy, CEO at Beyorch, a private equity firm in Los Angeles, Cal. "They are essential to expanding the sector." Going Forward Ultimately, investors' short-term sector issues against long-term potential will matter most, and lead them to choose sector stocks accordingly. "I suspect EV sales will be very strong in December due to the prospect of the tax credit going away and may slow down for a bit as the ultimate resolution of the tax credit is under discussion in Washington," Boyce says. "Over time, however, EVs will continue a growth trajectory." "Just how quick a growth trajectory really depends on where we land with the regulatory and tax environment in Washington," he adds. Step up your trading with Benzinga Pro's advanced news alerts, scanners, and real-time market insights. Join over 6,000 traders who rely on these tools to spot opportunities first. Start your free trial and trade smarter today. Image via Shutterstock © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

While Donald Trump’s lock on the white evangelical vote is legendary, he and his campaign allies also wooed smaller religious groups, far from the mainstream. Subscribe to continue reading this article. Already subscribed? To login in, click here.

resumed on Sunday, 24 November, with some viewers noticing a particularly NSFW recurrence on display. In the Tangled Worlds episode, the breeding habits of both Bengal tigers and purple frogs were respectfully documented in the first 20 minutes. Always with a sense of amusement, fans reacting on social media site X (formerly Twitter) were quick to highlight the continuous coverage of animal intimacy. Narrating an expanse of the tiger's territory, Attenborough explained: "It's the dry season. Between the trees, meadows of elephant grass provide cover for the most intimate of behaviours. In the last 10 years, the number of tigers in Nepal has doubled. "There are so many here that remarkably, pairs are mating within just 100 metres of each other." The corresponding action finished with the striped predators going their separate ways, as males do not engage in any parental duties. Further along, deep in the forests of India's Kerala state, the programme featured the plight of the purple frog, which emerge once every 12 months from their underground lair to breed. "This female has a belly full of eggs and on her back a newly acquired male partner," said Attenborough. "He grips her spine, making deep indentations in her flesh. They have timed their emergence to coincide with the monsoon rains. Somehow in the darkness they must find a tree in which to lay their eggs and then get back underground before dawn." Writing on X, : "Crap [can] we even show tiger mating this early in the day? There's children watching, Dave!" "Lots of rumpy [pumpy] in this episode this week!" . mass maiting — Havelock🌴🌻🍺👨‍🍳🎬🍷🔪🏎🪴 (@ihnewman) The problem with wildlife shows like Is that they are just filled with copulation and Death !! — paul j harrison (@pauharri) Tigers. Yet another creature that Pumps and Dumps! — Eamonn, Journeyman Reviewer (@RealEnli) Tell ya kids it's a piggy back ride! — Eamonn, Journeyman Reviewer (@RealEnli) Meanwhile, cameras later captured a herd of Asian elephants easily dismantling electric fences to reach plantations full of food. Attenborough revealed that Malaysian farmers have begun to encourage the enormous creatures onto their land; "Here the elephants are welcome. When old trees are felled, the herd can provide a waste disposal service."GAINESVILLE, Fla. (AP) — Princely Umanmielen's return to the Swamp ended with a police escort . Umanmielen, who spent three years at Florida before transferring to Ole Miss, left the stadium with a number of officers surrounding him. And the defensive end still tried to get at heckling fans. It started when Umanmielen left the sideline in the waning seconds of a 24-17 loss to the Gators . He was walking toward the visiting locker room when at least one fan yelled at him from the stands. Umanmielen clearly didn't like what he heard and made his way toward the seats. Officers quickly stepped in and escorted Umanmielen back toward the locker room. They then walked him directly to the team's waiting busses, but more fans were in the path and shouted at him again. Umanmielen turned and started toward the fans before officers stepped in and stopped him. It was the latest bit of oddness for Umanmielen, who wore an orange Gators ski mask through Ole Miss' practice facility late in the week. He finished the game with seven tackles, including a sack. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football

A bumper pace of new share sales across the Middle East in 2024 is expected to continue next year, even though a few recent disappointing trading debuts have flashed warning signs on valuations. Firms have raised $13bn from initial public offerings in 2024, marking the Middle East’s second-best year since the pandemic. But unlike in previous years, buoyant early returns are no longer a given. The three largest Gulf offerings of the year — Talabat Holding PLC, OQ Exploration & Production SAOG and Lulu Retail Holdings PLC — had muted debuts recently after drawing significant demand. Lulu and Talabat’s deals were both upsized at a late stage, potentially leading to oversupply, some analysts said. “Investors are expressing more sensitivity on valuation, and are more attuned to paying for growth companies as opposed to just buying the yield opportunities,” according to Ali Khalpey, head of equity capital markets at EFG Hermes. Still, as Gulf governments continue a push to diversify their economies and deepen capital markets, market participants expect the rush of listings to continue. “I don’t see anything stopping it,” said Andrew Briscoe, Bank of America Corp’s head of equity capital markets syndicate in Europe, the Middle East and Africa. “IPOs haven’t all worked well of late, but I don’t think it stops the issuance levels, although it might impact investor interest.” For context on how busy it’s been, the United Arab Emirates is set to be the leading venue for listings in the broader Europe, Middle East and Africa region for the third year in a row, according to data compiled by Bloomberg. The UAE and Saudi Arabia also rank among the top ten venues for share sales globally. There were also sizeable IPOs outside those markets. Two large deals helped Oman leapfrog the likes of UK and Germany by total volume of share sales. The sultanate has a further pipeline of about 30 assets it wants to privatise, including logistics company Asyad Group and Oman Electricity Transmission Co, while OQ also plans to line up further listings in coming years. In the UAE, Abu Dhabi’s flag carrier Etihad Airways is considering a landmark IPO that could make it the first Gulf hub carrier to go public, while a conglomerate owned by Dubai’s ruler is weighing two real estate listings. Other potential deals include a classifieds website, an information technology services firm and a construction company. Saudi Arabia is also likely to see a string of listings, potentially including low-cost carrier Flynas, buy-now-pay-later unicorn Tabby and tech firm Ejada. The country’s wealth fund, which has been on a drive to raise cash, could sell stakes in medical procurement firm Nupco and a port operator. EFG Hermes’ Khalpey expects the kingdom to generate the largest number of IPOs next year, including both state-owned and private businesses. “Many companies have scaled over the last few years and want to take advantage of the positive macro trends in the kingdom,” said Khalpey, whose bank has advised on the highest number of listings in the Gulf in 2024, according to Bloomberg’s league tables. “That’s going to crystallise in a number of IPOs from different sectors.” Recent Saudi listings such as United International Holding and Tamkeen have tended to buck the trend of muted early trading seen in the UAE and Oman. While the uptick in IPO activity in the US and Europe has given investors more choice and an opportunity to be more discerning, there are reasons to believe more international money will flow to the Gulf. The IPO boom of recent years has meant that Middle Eastern volumes are becoming a larger part of global indexes, making it harder for global fund managers to ignore the region, according to Rami Sidani, head of frontier investments at Schroder Investment Management. Lulu’s IPO, for one, drew in Vanguard Group Inc and Singapore sovereign wealth fund GIC Pte. Meanwhile, about 60% of Saudi Aramco’s $12bn sale of existing shares was allocated to foreign investors, a marked shift from its 2019 listing, where only 23% of the shares went to international buyers. That deal was one of three share offerings by public companies in the Middle East this year. While sales of new and existing shares in listed firms are still relatively rare in the Gulf, more are expected next year. That will give investors opportunities to top up on stocks they might have missed out on during IPOs, while also helping firms reach the level of free float they need to be included in indexes. “Companies looking to do follow-ons will have to compete for investor attention amid a number of new names,” said Samer Deghaili, co-head of investment banking for the Middle East, North Africa and Turkey at HSBC Holdings Plc, which is the top-ranked institution for regional equity offerings by value, according to Bloomberg’s league tables. “For a company to do a follow-on, they will have to offer a strong growth story where investors can still come in and top up in the stock,” Deghaili said. Related Story Qatar-Morocco 2024 Year ends with Tbourida art shows Ajyal 2024 marks Qatar–Morocco 2024 YoC( MENAFN - EIN Presswire) Cataract Surgery Devices And Equipment Global market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 20, 2024 /EINPresswire / -- Don't miss The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only! What Is Driving The Growth Of The Cataract Surgery Devices And Equipment Market? The cataract surgery devices and equipment market has seen exponential growth in recent years. It is expected to surge from $7.46 billion in 2023 to $8.24 billion in 2024, with a compound annual growth rate CAGR of 10.5%. This growth during the historical period can be attributed to aging population demographics, increasing incidence of cataracts, heightened patient awareness, government initiatives for vision care, as well as increasing healthcare expenditure. What Is Projected For The Cataract Surgery Devices And Equipment Market? The market is expected to witness robust growth in the forecast period, reaching $11.84 billion in 2028 at a CAGR of 9.5%. This anticipated growth momentum can be accredited to a growing focus on outpatient surgery, customized intraocular lenses, value-based healthcare models, global vision care campaigns, global initiatives for eye health and significant strides in AI integration, teleophthalmology, remote consultations, rapid technological innovations, improvements in intraocular lens technology, and surgical techniques, particularly femtosecond laser technology. Sample the report here: What Factors Are Driving The Growth Of The Cataract Surgery Devices And Equipment Market? The rising geriatric population, more prone to developing cataracts as they age, is expected to fuel the growth of the cataract surgery devices and equipment market in the future. For instance, according to the 2021 American Community Survey conducted by The United States Census Bureau, there were 55,892,014 people aged 65 and over in the U.S., representing about 16.8% of the population. With age, the prevalence of cataracts increases, thereby escalating demand for cataract surgery devices due to associated vision impairment. What Are The Key Industry Players And Emerging Trends In The Cataract Surgery Devices And Equipment Market? Major companies operating in the cataract surgery devices and equipment market include Johnson & Johnson Services Inc., Allergan Inc., PhysIOL S.A, Novartis AG, Abbott Laboratories, Alcon Inc., HOYA Corporation, Bausch & Lomb Inc., Carl Zeiss Meditech AG, Topcon Corporation, NIDEK Co. Ltd., Glaukos Corporation, Aurolab Co., OPHTEC BV, DORC International BV, Calhoun Vision Inc., Coburn Technologies Inc., HumanOptics AG, Hanita Lenses Ltd., Lenstec Inc., CRISTALENS SL, and EyeKon Medical Inc., among others. In developing innovative products, such as the VERITAS Vision System, these companies aim to improve surgical accuracy and outcomes. Designed to enhance patient safety, surgeon efficiency, and comfort, the VERITAS Vision System was launched by Johnson & Johnson Vision in July 2021. It utilizes hybrid fluidics technology and White star technology to facilitate cataract surgery with more stability and less surge, thereby improving surgical outcomes. Buy the full report here: How Is The Global Cataract Surgery Devices And Equipment Market Segmented? The market is broadly segmented: 1 By Type: Intraocular Lens IOL, Ophthalmic viscoelastic device OVD, Phacoemulsification Equipment, Femtosecond Laser Equipment. 2 By Surgery Type: Extracapsular Cataract Extraction, Phacoemulsification, Femtosecond Laser, Other Surgery Types. 3 By Application: Ophthalmology Centers, Hospitals, Clinics. What Are The Regional Insights Into The Cataract Surgery Devices And Equipment Market? In 2023, North America was the largest player in the global cataract surgery devices and equipment market, closely followed by Asia-Pacific. The regions analyzed in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Browse more similar reports- Ophthalmic Devices Global Market Report 2024 Ophthalmic Medical Lasers Global Market Report 2024 Macular Degeneration Treatment Global Market Report 2024 The Business Research Company has published over 15000+ reports in 27 industries across 60+ geographies. Our exceptional reports, built on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders, provide valuable insights into potential opportunities and strategies. Contact us at The Business Research Company: Americas: +1 3156230293 Asia: +44 2071930708 Europe: +44 2071930708 Email us at ... Follow us on LinkedIn: YouTube: Global Market Model: global-market-model Oliver Guirdham The Business Research Company +44 20 7193 0708 email us here Visit us on social media: Facebook X LinkedIn Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. MENAFN19122024003118003196ID1109014324 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Dhruvan Rajesh would not be here were it not for the kindness of strangers. Subscribe now for unlimited access . Login or signup to continue reading All articles from our website & app The digital version of Today's Paper Breaking news alerts direct to your inbox Interactive Crosswords, Sudoku and Trivia All articles from the other regional websites in your area Continue He had been in Canberra for a week when he felt pins and needles in his legs. He tried to stand and walk but collapsed on the floor. "I just fell over, and that was very scary," the 18-year-old who has just graduated from Canberra College said. He had Guillain-Barre Syndrome, a rare condition where the nervous system is attacked. Fortunately, there was enough plasma at Canberra Hospital to save his life and, two years later, to have pretty well cured him. His muscles still get tired but it's getting better - thanks to the part of the blood called plasma donated by someone he will never know. Canberra student Dhurvan Rajesh whose life was saved by blood and plasma donations. Picture by Karleen Minney. So he is urging Canberrans to donate over this coming holiday season when the need for it goes through the roof. It will save lives but also, he said, help the donor too. "When you do something which will have a positive effect, it makes your day," he said. "You are also helping people like me who need plasma. "Thanks to this treatment, I slowly regained my mobility. After weeks of physiotherapy, I was able to walk normally again. "But as I recovered, I began to realise something even more profound: My ability to stand, to walk, to return to school and build a future wasn't just thanks to incredible medical professionals or advanced treatments. "It was because of the generosity of strangers." The Australian Red Cross's Lifeblood organisation is asking for more generosity from Canberra strangers over the coming two weeks. There are three main centres: The Mobile Donor Centre in Garema Place in Civic from December 18 to 24. The Mobile Donor Centre at The Valley Avenue in Gungahlin from December 26 to January 5. And the Garran Donor Centre at Red Cross House on Dann Close which is open every day, including Christmas morning. You can book online on the Lifeblood website or by calling 13 14 95. Lifeblood said it needed an extra 35 donors in the ACT each day until January 2 "to meet the demand for blood products in hospitals over the holiday season". Part of the increased need for donors is a spike in demand because of car accidents, for example. A bad car accident demands large amounts of blood to keep victims alive. Apart from that, plasma is the largest part of our blood, and it is increasingly used in the treatment of cancer patients. The need for it has never been higher. The other reason Lifeblood wants more donors at this time of year is that hospitals try to get patients home for Christmas so they treat them to free them to their families - and treatment demands blood. "People of all ages will rely on blood and blood products in the coming weeks including those with immune conditions and cancer, trauma patients, and women having babies," Lifeblood's director of donor experience, Cath Stone, said. "It is vital to have a constant stream of donors to ensure patient needs are met." Dhruvan Rajesh echoed the appeal. "You are saving someone's life which is the best thing you can do," he said. He has just left school and is heading for the University of Canberra. He hopes to teach biology. Share Facebook Twitter Whatsapp Email Copy Steve Evans Reporter Steve Evans is a reporter on The Canberra Times. He's been a BBC correspondent in New York, London, Berlin and Seoul and the sole reporter/photographer/paper deliverer on The Glen Innes Examiner in country New South Wales. "All the jobs have been fascinating - and so it continues." Steve Evans is a reporter on The Canberra Times. He's been a BBC correspondent in New York, London, Berlin and Seoul and the sole reporter/photographer/paper deliverer on The Glen Innes Examiner in country New South Wales. "All the jobs have been fascinating - and so it continues." More from Canberra Dhruvan would not be here were it not for the kindness of strangers 1hr ago No comment s Here's the most repulsive thing about private education 1hr ago No comment s 'It does not make sense': Minister asks Big Splash owner to reveal intentions 1hr ago No comment s Violence, graffiti and bust businesses: revamped Dickson not what was hoped 1hr ago No comment s The $22.5m investment in Canberra that will help to run the new AUKUS subs No comment s Labor has to grapple with Anthony Albanese's 'man problem' No comment s Newsletters & Alerts View all DAILY Your morning news Today's top stories curated by our news team. Also includes evening update. Loading... WEEKDAYS The lunch break Grab a quick bite of today's latest news from around the region and the nation. Loading... DAILY Sport The latest news, results & expert analysis. Loading... WEEKDAYS The evening wrap Catch up on the news of the day and unwind with great reading for your evening. Loading... WEEKLY Note from the Editor Get the editor's insights: what's happening & why it matters. Loading... WEEKLY FootyHQ Love footy? We've got all the action covered. Loading... DAILY Early Look At David Pope Your exclusive preview of David Pope's latest cartoon. Loading... AS IT HAPPENS Public Service News Don't miss updates on news about the Public Service. Loading... WEEKLY Explore Travel Every Saturday and Tuesday, explore destinations deals, tips & travel writing to transport you around the globe. Loading... WEEKLY Property Get the latest property and development news here. Loading... WEEKLY What's On Going out or staying in? Find out what's on. Loading... WEEKLY Weekend Reads We've selected the best reading for your weekend. Loading... WEEKLY Times Reader's Panel Join our weekly poll for Canberra Times readers. Loading... WEEKDAYS The Echidna Sharp. Close to the ground. Digging deep. Your weekday morning newsletter on national affairs, politics and more. Loading... TWICE WEEKLY The Informer Your essential national news digest: all the big issues on Wednesday and great reading every Saturday. Loading... WEEKLY Motoring Get news, reviews and expert insights every Thursday from CarExpert, ACM's exclusive motoring partner. Loading... TWICE WEEKLY Voice of Real Australia Get real, Australia! Let the ACM network's editors and journalists bring you news and views from all over. Loading... AS IT HAPPENS Breaking news alert Be the first to know when news breaks. Loading... DAILY Today's Paper Alert Your digital replica of Today's Paper. Ready to read from 5am! Loading... DAILY Your favourite puzzles Test your skills with interactive crosswords, sudoku & trivia. Fresh daily! Loading...